Global Cancer Informatics Market Analysis, 2021

Market Overview

Cancer Informatics is a comprehensive information solution that explores the crucial technologies, informatics trends of applying computational biology to cancer research and care. In Cancer Informatics, computer & information science and healthcare interconnect to acquire, store and use information regarding cancer thoroughly & efficiently.

According to the publisher's research report, Global Cancer Informatics Market Analysis, 2021, the market is likely to grow at a CAGR of around 7.5% during 2021-26. The growth of the cancer informatics market attributes to the rising prevalence of cancer, surging costs of cancer treatment, and mounting focus on reducing medical errors & readmission rates. However, the high costs involved while installing these solutions are amongst the most prominent challenges for the market.

Impact of COVID-19

The outbreak of the COVID-19 pandemic has adversely affected cancer patients as most cancer patients are of older age and immunosuppressed. Additionally, lockdown imposition, social distancing measures, and the need for isolation in the pandemic-frenzied world have been convenient factors for delayed follow-up and postponement in routine screening procedures. However, the market players are focused on developing cloud and AI-based technologies to control the impact of the COVID-19 pandemic on the cancer informatics market.

Medical Application Accounted for the Largest Market Share

Based on the Application, the market classifies into medical, surgical, and radiation applications. The Medical application acquired the largest share in the global cancer informatics market in the previous year. The growth attributes to the rising usage of immunotherapy & chemotherapy and snowballing cancer informatics to manage & analyze patient information and predict treatment, thereby improving survival rates and presenting growth opportunities for the market, reveals the author in their research report, Global Cancer Informatics Market Analysis, 2021.

Electronic Health Records (EHRs) Dominated the Market

Electronic Health Records accounted for the largest market share in the global cancer informatics market in the previous few years. Electronic Health Records are electronic versions of a patient’s medical history consisting of their relevant clinical data under a particular provider. With the help of EHR, the medical record-keeping procedure becomes more centralized and easily accessible.

Additionally, EHR offers numerous other benefits, such as enhanced quality of patient care, reduced health care costs, and an easy transfer of a patient’s information among providers, thereby contributing to the growth of the cancer informatics market in the forecast period.

Regional Landscape

North America Grabbed the Largest Market Share

Region-wise, North America held the largest market share in the global cancer informatics market in the previous year due to the rising adoption of advanced technologies in the healthcare sector and mounting investments by pharmaceutical industries. The United States dominates the North American region due to the surging number of cancer patients and massive investments in cancer R&D.

Market Driver

Emerging Technological Advancements Drives the Market Growth

Soaring adoption of advanced technologies in healthcare leads to enhanced diagnostic methods for better treatment and reduced readmission rates. Further, the integrated diagnostic approach helps accurately formulate the way for precision medicine, which would also help provide appropriate treatments and reduce errors in the clinical workflow.

Competitive Landscape

According to the publishers, the major leading players in the global Cancer Informatics market are Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation, etc.

Key Questions Answered in the Market Research Report:

1. What are the overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Global Cancer Informatics Market?
2. What are the region-wise industry size, growth drivers, and challenges?
3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Cancer Informatics Market?
4. Who are the key competitors, their key strengths & weaknesses, and how do they perform in Global Cancer Informatics Market based on a competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the Global Cancer Informatics Market study?

1. Introduction

1.1. Product Definition
1.2. Research Process
1.3. Market Segmentation
1.4. Assumptions

2. Preface3. Executive Summary4. Impact of COVID-19 on Global Cancer Informatics Market

5. Global Cancer Informatics Market Dynamics

5.1. Growth Drivers
5.2. Challenges
5.3. Impact Analysis

6. Global Cancer Informatics Market Policies and Product Standards7. Global Cancer Informatics Market Trends & Insights8. Global Cancer Informatics Market Hotspot & Opportunities9. Global Cancer Informatics Market Key Strategic Imperatives for Success & Growth

10. Global Cancer Informatics Market Outlook, 2016-2026F

10.1. Market Size & Analysis
10.1.1. By Revenues
10.2. Market Share & Analysis
10.2.1. By Product
10.2.1.1. Electronic Health Records (EHRs)
10.2.1.2. Population Health Management (PHM)
10.2.1.3. Clinical Decision Support System (CDSS)
10.2.1.4. Drug Discovery and Development Informatics (DDDI)
10.2.2. By Application
10.2.2.1. Medical Application
10.2.2.2. Surgical Application
10.2.2.3. Radiation Application
10.2.3. By Cancer Type
10.2.3.1. Breast Cancer
10.2.3.2. Prostate Cancer
10.2.3.3. Colorectal Cancer
10.2.3.4. Cervical Cancer
10.2.3.5. Other
10.2.4. By End-Users
10.2.4.1. Life Science industry
10.2.4.2. Academic Institutes and Research Centers
10.2.4.3. Pharmaceutical Companies
10.2.4.4. Contract Research Organizations (CROs)
10.2.4.5. Others (Hospitals and Other Care Facilities)
10.2.5. By Region
10.2.5.1. North America
10.2.5.2. Latin America
10.2.5.3. Europe
10.2.5.4. Middle East & Africa
10.2.5.5. Asia-Pacific
10.2.6. By Company
10.2.6.1. Competition Characteristics
10.2.6.2. Market Share & Analysis
10.2.6.3. Competitive Matrix

11. North America Cancer Informatics Market Outlook, 2016-2026F

11.1. Market Size & Analysis
11.1.1. Revenues
11.2. Market Share & Analysis
11.2.1. By Product
11.2.2. By Application
11.2.3. By Cancer Type
11.2.4. By End-Users
11.2.5. By Country
11.2.5.1. The US
11.2.5.2. Canada
11.3. The US Cancer Informatics Market Outlook, 2016-2026F
11.3.1. Market Size & Analysis
11.3.1.1. Revenues
11.3.2. Market Share & Analysis
11.3.2.1. By Product
11.3.2.2. By Application
11.3.2.3. By Cancer Type
11.3.2.4. By End-Users
11.4. Canada Cancer Informatics Market Outlook, 2016-2026F
11.4.1. Market Size & Analysis
11.4.1.1. Revenues
11.4.2. Market Share & Analysis
11.4.2.1. By Product
11.4.2.2. By Application
11.4.2.3. By Cancer Type
11.4.2.4. By End-Users

12. Latin America Cancer Informatics Market Outlook, 2016-2026F

12.1. Market Size & Analysis
12.1.1. Revenues
12.2. Market Share & Analysis
12.2.1. By Product
12.2.2. By Application
12.2.3. By Cancer Type
12.2.4. By End-Users
12.2.5. By Country
12.2.5.1. Brazil
12.2.5.2. Mexico
12.2.5.3. Others
12.3. Brazil Cancer Informatics Market Outlook, 2016-2026F
12.3.1. Market Size & Analysis
12.3.1.1. Revenues
12.3.2. Market Share & Analysis
12.3.2.1. By Product
12.3.2.2. By Application
12.3.2.3. By Cancer Type
12.3.2.4. By End-Users
12.4. Mexico Cancer Informatics Market Outlook, 2016-2026F
12.4.1. Market Size & Analysis
12.4.1.1. Revenues
12.4.2. Market Share & Analysis
12.4.2.1. By Product
12.4.2.2. By Application
12.4.2.3. By Cancer Type
12.4.2.4. By End-Users

13. Europe Cancer Informatics Market Outlook, 2016-2026F

13.1. Market Size & Analysis
13.1.1. Revenues
13.2. Market Share & Analysis
13.2.1. By Product
13.2.2. By Application
13.2.3. By Cancer Type
13.2.4. By End-Users
13.2.5. By Country
13.2.5.1. The UK
13.2.5.2. Italy
13.2.5.3. Germany
13.2.5.4. France
13.2.5.5. Spain
13.2.5.6. Russia
13.3. The UK Cancer Informatics Market Outlook, 2016-2026F
13.3.1. Market Size & Analysis
13.3.1.1. Revenues
13.3.2. Market Share & Analysis
13.3.2.1. By Product
13.3.2.2. By Application
13.3.2.3. By Cancer Type
13.3.2.4. By End-Users
13.4. Italy Cancer Informatics Market Outlook, 2016-2026F
13.4.1. Market Size & Analysis
13.4.1.1. Revenues
13.4.2. Market Share & Analysis
13.4.2.1. By Product
13.4.2.2. By Application
13.4.2.3. By Cancer Type
13.4.2.4. By End-Users
13.5. Germany Cancer Informatics Market Outlook, 2016-2026F
13.5.1. Market Size & Analysis
13.5.1.1. Revenues
13.5.2. Market Share & Analysis
13.5.2.1. By Product
13.5.2.2. By Application
13.5.2.3. By Cancer Type
13.5.2.4. By End-Users
13.6. France Cancer Informatics Market Outlook, 2016-2026F
13.6.1. Market Size & Analysis
13.6.1.1. Revenues
13.6.2. Market Share & Analysis
13.6.2.1. By Product
13.6.2.2. By Application
13.6.2.3. By Cancer Type
13.6.2.4. By End-Users
13.7. Spain Cancer Informatics Market Outlook, 2016-2026F
13.7.1. Market Size & Analysis
13.7.1.1. Revenues
13.7.2. Market Share & Analysis
13.7.2.1. By Product
13.7.2.2. By Application
13.7.2.3. By Cancer Type
13.7.2.4. By End-Users
13.8. Russia Cancer Informatics Market Outlook, 2016-2026F
13.8.1. Market Size & Analysis
13.8.1.1. Revenues
13.8.2. Market Share & Analysis
13.8.2.1. By Product
13.8.2.2. By Application
13.8.2.3. By Cancer Type
13.8.2.4. By End-Users

14. Middle East & Africa Cancer Informatics Market Outlook, 2016-2026F

14.1. Market Size & Analysis
14.1.1. Revenues
14.2. Market Share & Analysis
14.2.1. By Product
14.2.2. By Application
14.2.3. By Cancer Type
14.2.4. By End-Users
14.2.5. By Country
14.2.5.1. Saudi Arabia
14.2.5.2. South Africa
14.2.5.3. Rest of the Middle East & Africa
14.3. Saudi Arabia Cancer Informatics Market Outlook, 2016-2026F
14.3.1. Market Size & Analysis
14.3.1.1. Revenues
14.3.2. Market Share & Analysis
14.3.2.1. By Product
14.3.2.2. By Application
14.3.2.3. By Cancer Type
14.3.2.4. By End-Users
14.4. South Africa Cancer Informatics Market Outlook, 2016-2026F
14.4.1. Market Size & Analysis
14.4.1.1. Revenues
14.4.2. Market Share & Analysis
14.4.2.1. By Product
14.4.2.2. By Application
14.4.2.3. By Cancer Type
14.4.2.4. By End-Users

15. Asia-Pacific Cancer Informatics Market Outlook, 2016-2026F

15.1. Market Size & Analysis
15.2. Revenues
15.3. Market Share & Analysis
15.3.1. By Product
15.3.2. By Application
15.3.3. By Cancer Type
15.3.4. By End-Users
15.3.5. By Country
15.3.5.1. China
15.3.5.2. Japan
15.3.5.3. India
15.3.5.4. South Korea
15.3.5.5. Australia
15.3.5.6. Others
15.4. China Cancer Informatics Market Outlook, 2016-2026F
15.4.1. Market Size & Analysis
15.4.1.1. Revenues
15.4.2. Market Share & Analysis
15.4.2.1. By Product
15.4.2.2. By Application
15.4.2.3. By Cancer Type
15.4.2.4. By End-Users
15.5. Japan Cancer Informatics Market Outlook, 2016-2026F
15.5.1. Market Size & Analysis
15.5.1.1. Revenues
15.5.2. Market Share & Analysis
15.5.2.1. By Product
15.5.2.2. By Application
15.5.2.3. By Cancer Type
15.5.2.4. By End-Users
15.6. India Cancer Informatics Market Outlook, 2016-2026F
15.6.1. Market Size & Analysis
15.6.1.1. Revenues
15.6.2. Market Share & Analysis
15.6.2.1. By Product
15.6.2.2. By Application
15.6.2.3. By Cancer Type
15.6.2.4. By End-Users
15.7. South Korea Cancer Informatics Market Outlook, 2016-2026F
15.7.1. Market Size & Analysis
15.7.1.1. Revenues
15.7.2. Market Share & Analysis
15.7.2.1. By Product
15.7.2.2. By Application
15.7.2.3. By Cancer Type
15.7.2.4. By End-Users
15.8. Australia Cancer Informatics Market Outlook, 2016-2026F
15.8.1. Market Size & Analysis
15.8.1.1. Revenues
15.8.2. Market Share & Analysis
15.8.2.1. By Product
15.8.2.2. By Application
15.8.2.3. By Cancer Type
15.8.2.4. By End-Users

16. Competition Outlook

16.1. Competition Matrix
16.1.1. Product/ Solution Portfolio
16.1.2. Target Markets
16.1.3. Target End Users
16.1.4. Research & Development
16.1.5. Strategic Alliances
16.1.6. Strategic Initiatives

17. Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)

17.1. Elekta ab
17.2. Varian Medical Systems
17.3. Accuray Incorporated
17.4. Cerner Corporation
17.5. RaySearch Laboratories
17.6. Flatiron
17.7. Oncology Analytics, Inc
17.8. Hologic Inc.
17.9. F.Hoffmann-La Roche Ltd.
17.10. McKesson Corporation

18. Disclaimer